SCHEMBL5593735

SCHEMBL5593735

Nc1cccc2ccc(I)c(S(=O)(=O)O)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.39
JAK2 O60674 1/20 0.38
RPS6KA3 P51812 1/20 0.38
MELK Q14680 1/20 0.38
STK24 Q9Y6E0 1/20 0.38
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
TYMS P04818 1/20 0.36
GLO1 Q04760 1/20 0.35
ALDH1A1 P00352 6/20 0.33
HSD17B10 Q99714 4/20 0.33
TSHR P16473 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
CASP6 P55212 2/20 0.33
CDK2 P24941 2/20 0.33
FABP4 P15090 1/20 0.33
CCNA2 P20248 1/20 0.33
MAPK14 Q16539 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28065908 0.83 AURKA (0.50) TTRJAK2RPS6KA3MELKSTK24
SCHEMBL8077141 0.81 AURKA (0.45) TTRJAK2RPS6KA3MELKSTK24
SCHEMBL10797668 0.78 TTR (0.46) TTRAURKAAURKBALDH1A1HSD17B10
SCHEMBL28118203 0.73 AURKA (0.44) TTRJAK2RPS6KA3MELKSTK24
SCHEMBL4763755 0.73 TTR (0.46) TTRJAK2RPS6KA3MELKSTK24
SCHEMBL625075 0.73 FABP4 (0.63) TTRALDH1A1HSD17B10TSHRTDP1
SCHEMBL29360969 0.73 TTR (0.58) TTRJAK2RPS6KA3MELKSTK24
SCHEMBL179823 0.73 TTR (0.58) TTRJAK2RPS6KA3MELKSTK24
Water SCHEMBL7765550 0.72 TTR (0.56) TTRJAK2RPS6KA3MELKSTK24
SCHEMBL21240726 0.72 TTR (0.56) TTRJAK2RPS6KA3MELKSTK24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814598-A2 CONTRAST AGENTS TO TARGET EXTRACELLULAR MATRIX GE Healthcare AS (NO) 2007-08-08 EP disclosed
WO-2006054904-A2 CONTRAST AGENTS TO TARGET EXTRACELLULAR MATRIX GE HEALTHCARE AS (NO) 2006-05-26 WO disclosed